1. Where a Member State, as a result of new or additional information made
available since the date of the consent and affecting the environmental risk assessment or reassessment of existing information on the basis o
f new or additional scientific knowledge, has detailed grounds for considering that a GMO as or in a product which has been properly notified and has received written consent under this Directive constitutes a risk to human health or the environment, that Member State may provisionally restrict or prohibit the use and/or
...[+++]sale of that GMO as or in a product on its territory.